A Novel MYH9-RET Fusion Occurrence and EGFR T790M Loss as an Acquired Resistance Mechanism to Osimertinib in a Patient with Lung Adenocarcinoma: A Case Report

Yanwei Sun,1 Lina Pei,2 Ningning Luo,3 Dongsheng Chen,3 Lingxin Meng1 1Department of Oncology, People’s Hospital of Rizhao, Rizhao, People’s Republic of China; 2Department of Pharmacy, People’s Hospital of Rizhao, Rizhao, People’s Republic of China; 3The State...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Sun Y, Pei L, Luo N, Chen D, Meng L
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2020-11-01
Edice:OncoTargets and Therapy
Témata:
myh9-ret fusion
egfr exon20 p.t790m loss
lung adenocarcinoma
acquired resistance
osimertinib
On-line přístup:https://www.dovepress.com/a-novel-myh9-ret-fusion-occurrence-and-egfr-t790m-loss-as-an-acquired--peer-reviewed-article-OTT
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky